Literature DB >> 6586496

Opposite and mutually incompatible structural requirements of type-2 casein kinase and cAMP-dependent protein kinase as visualized with synthetic peptide substrates.

L A Pinna, F Meggio, F Marchiori, G Borin.   

Abstract

The synthetic hexapeptide Ser-Glu-Glu-Glu-Val-Glu and its N-acetylated derivative are readily and specifically phosphorylated by rat liver casein kinase TS (type-2), while the derived heptapeptide with an additional N-terminal Arg is a very poor substrate. Conversely, the substitution of Glu for Val5 in the synthetic peptide Arg-Arg-Ser-Thr-Val-Ala, which is a good substrate for cAMP-dependent protein kinase by virtue of the N-terminal arginyl residues, prevents its phosphorylation by this enzyme. These data indicate that the site specificities of these two classes of protein kinases, requiring acidic and basic residues on the C- and N-terminal sides of the target residue(s), respectively, are mutually incompatible.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6586496     DOI: 10.1016/0014-5793(84)80490-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Purification of a soluble casein kinase II from Dictyostelium discoideum lacking the beta subunit: regulation during proliferation and differentiation.

Authors:  B Ospina; A Núñez; M Fernández-Renart
Journal:  Mol Cell Biochem       Date:  1992-12-02       Impact factor: 3.396

2.  A synthetic peptide substrate specific for casein kinase II.

Authors:  E A Kuenzel; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

3.  Substrate specificity of the herpes simplex virus type 2 UL13 protein kinase.

Authors:  Gina L Cano-Monreal; John E Tavis; Lynda A Morrison
Journal:  Virology       Date:  2008-01-22       Impact factor: 3.616

4.  Myc oncoproteins are phosphorylated by casein kinase II.

Authors:  B Lüscher; E A Kuenzel; E G Krebs; R N Eisenman
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.